Anti-Human ANXA1 Monoclonal Antibody (1A506) from ProteoGenix; catalogue ARO-A23274; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human ANXA1 Monoclonal Antibody (1A506) is a highly specialized and potent tool for biotech research. This antibody specifically targets Annexin A1, a protein that plays a crucial role in various cellular processes such as inflammation and apoptosis.
With its high specificity and affinity, the Anti-Human ANXA1 Monoclonal Antibody (1A506) is an ideal choice for studying the function and regulation of Annexin A1 in different biological systems. It has been extensively validated and has shown excellent performance in a variety of applications.
One of the main applications of this antibody is in studying the role of Annexin A1 in inflammation. By targeting this protein, researchers can gain a better understanding of the underlying mechanisms of inflammation and develop potential therapeutic strategies for inflammatory diseases.
In addition, the Anti-Human ANXA1 Monoclonal Antibody (1A506) has also been used in cancer research. Annexin A1 has been shown to play a role in tumor growth and metastasis, and this antibody can help researchers investigate its involvement in different types of cancer.
This antibody is also widely used in experimental models, such as Western blotting, immunofluorescence, and immunohistochemistry. Its high specificity and sensitivity make it a valuable tool for detecting and quantifying Annexin A1 in various samples.
In summary, the Anti-Human ANXA1 Monoclonal Antibody (1A506) is a powerful and versatile tool for studying Annexin A1 in different biological systems. Its high specificity, sensitivity, and reliability make it a top choice for researchers in the biotech industry. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A23274. For research use only.
Target: Annexin A1, Annexin I, Annexin-1, Calpactin II, Calpactin-2, Chromobindin-9, Lipocortin I, Phospholipase A2 inhibitory protein, p35, Annexin Ac2-26, ANXA1; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
